BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 32375324)

  • 1. Human Ovarian Cortex biobanking: A Fascinating Resource for Fertility Preservation in Cancer.
    Silvestris E; De Palma G; Canosa S; Palini S; Dellino M; Revelli A; Paradiso AV
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32375324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer: an update on treatment-related infertility.
    Silvestris E; Dellino M; Cafforio P; Paradiso AV; Cormio G; D'Oronzo S
    J Cancer Res Clin Oncol; 2020 Mar; 146(3):647-657. PubMed ID: 32006118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro maturation of human immature oocytes for fertility preservation.
    Chian RC; Uzelac PS; Nargund G
    Fertil Steril; 2013 Apr; 99(5):1173-81. PubMed ID: 23433515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response.
    Volodarsky-Perel A; Cohen Y; Arab S; Son WY; Suarthana E; Dahan MH; Tulandi T; Buckett W
    Hum Reprod; 2019 Mar; 34(3):530-538. PubMed ID: 30689898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fertility preservation in oncology].
    Chaput L; Grémeau AS; Vorilhon S; Pons H; Chabrot C; Grèze V; Pouly JL; Brugnon F
    Bull Cancer; 2018 Jan; 105(1):99-110. PubMed ID: 29221621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
    Abir R; Ben-Aharon I; Garor R; Yaniv I; Ash S; Stemmer SM; Ben-Haroush A; Freud E; Kravarusic D; Sapir O; Fisch B
    Hum Reprod; 2016 Apr; 31(4):750-62. PubMed ID: 26848188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotropin-releasing hormone agonist trigger increases the number of oocytes and embryos available for cryopreservation in cancer patients undergoing ovarian stimulation for fertility preservation.
    Pereira N; Kelly AG; Stone LD; Witzke JD; Lekovich JP; Elias RT; Schattman GL; Rosenwaks Z
    Fertil Steril; 2017 Sep; 108(3):532-538. PubMed ID: 28865552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel aspects on gonadotoxicity and fertility preservation in lymphoproliferative neoplasms.
    Silvestris E; Cormio G; Skrypets T; Dellino M; Paradiso AV; Guarini A; Minoia C
    Crit Rev Oncol Hematol; 2020 Jul; 151():102981. PubMed ID: 32485429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Real-Life Analysis of Reproductive Outcome after Fertility Preservation in Female Cancer Patients.
    Hulsbosch S; Koskas M; Tomassetti C; De Sutter P; Wildiers H; Neven P; D'Hooghe T; Amant F
    Gynecol Obstet Invest; 2018; 83(2):156-163. PubMed ID: 29050014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Female fertility preservation: past, present and future.
    Fisch B; Abir R
    Reproduction; 2018 Jul; 156(1):F11-F27. PubMed ID: 29581237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study.
    Diaz-Garcia C; Domingo J; Garcia-Velasco JA; Herraiz S; Mirabet V; Iniesta I; Cobo A; Remohí J; Pellicer A
    Fertil Steril; 2018 Mar; 109(3):478-485.e2. PubMed ID: 29428307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryopreservation of Oocytes Retrieved from Ovarian Tissue to Optimize Fertility Preservation in Prepubertal Girls and Women.
    Brouillet S; Ferrieres-Hoa A; Fournier A; Martinez G; Bessonnat J; Gueniffey A; Gala A; Loup V; Hamamah S
    J Vis Exp; 2020 Oct; (164):. PubMed ID: 33165323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients.
    Grynberg M; Poulain M; le Parco S; Sifer C; Fanchin R; Frydman N
    Hum Reprod; 2016 Mar; 31(3):623-9. PubMed ID: 26759139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fertility preservation options in breast cancer patients.
    Kasum M; von Wolff M; Franulić D; Čehić E; Klepac-Pulanić T; Orešković S; Juras J
    Gynecol Endocrinol; 2015; 31(11):846-51. PubMed ID: 26370157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryopreservation of ovarian tissue for fertility preservation in young female oncological patients.
    Andersen CY; Kristensen SG; Greve T; Schmidt KT
    Future Oncol; 2012 May; 8(5):595-608. PubMed ID: 22646773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian tissue cryopreservation for fertility preservation in 418 girls and adolescents up to 15 years of age facing highly gonadotoxic treatment. Twenty years of experience at a single center.
    Poirot C; Brugieres L; Yakouben K; Prades-Borio M; Marzouk F; de Lambert G; Pacquement H; Bernaudin F; Neven B; Paye-Jaouen A; Pondarre C; Dhedin N; Drouineaud V; Chalas C; Martelli H; Michon J; Minard V; Lezeau H; Doz F; Sarnacki S; Philippe-Chomette P; Dufour C; Laurence V; Baruchel A; Wolf JP; Boissel N; Valteau-Couanet D; Dalle JH
    Acta Obstet Gynecol Scand; 2019 May; 98(5):630-637. PubMed ID: 30919447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fertility preservation techniques in women of reproductive age ].
    Vulliemoz N ; Gaitzsch H ; Primi M-P ; Wunder D ; Perey L ; Streuli I
    Rev Med Suisse; 2014 Oct; 10(447):1961-2, 1964-6, 1968. PubMed ID: 25518205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fertility preservation in women with oncologic disease].
    Freitas C; Brazão K; Farinha Â; Vieira J; Ferreira M
    Acta Med Port; 2011 Dec; 24 Suppl 4():881-8. PubMed ID: 22863496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oncofertility and breast cancer].
    Sonigo C; Grynberg M; Bringer S; Sermondade N
    Bull Cancer; 2019 Dec; 106(12S1):S43-S52. PubMed ID: 32008738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of women and girls undergoing fertility preservation due to oncologic and non-oncologic indications in Sweden-Trends in patients' choices and benefit of the chosen methods after long-term follow up.
    Rodriguez-Wallberg KA; Marklund A; Lundberg F; Wikander I; Milenkovic M; Anastacio A; Sergouniotis F; Wånggren K; Ekengren J; Lind T; Borgström B
    Acta Obstet Gynecol Scand; 2019 May; 98(5):604-615. PubMed ID: 30723910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.